fbpx

GBM Awareness Day is July 17. Join us in raising awareness all month long! Learn more.

Primitive Neuroectodermal Tumor (PNET)

Play Video about video overlay

Primitive Neuroectodermal Tumor (PNET)

Primitive Neuroectodermal Tumor, also referred to as PNET, is a category of malignant (cancerous) tumors which appear similar under the microscope to medulloblastoma but occur primarily in the top part of the brain (the cerebrum). This category of tumors is molecularly and clinically diverse and includes the following diagnoses:

Pineoblastoma

  • CNS neuroblastoma with FOXR2 activation
  • CNS high-grade neuroepithelial tumor with BCOR alteration
  • CNS Ewing sarcoma family tumor with CIC alteration
  • CNS high-grade neuroepithelial tumor with MN1 alteration
  • CNS embryonal tumor not otherwise specified

Individually, each of these are very rare tumors.

Location

PNETs occur primarily in the cerebrum but can spread to other parts of the brain and spine.

Symptoms

Because they tend to be large tumors, symptoms are often due to increased pressure in the brain. These include headaches, morning vomiting, blurry vision, and behavioral changes, and seizures.

Treatment

Surgery is the standard initial treatment for these tumors. Because of their large size, tendency to spread, and extensive blood supply, total removal may not be possible at the time of diagnosis, and chemotherapy may be used to shrink the tumor to make surgical removal safer.

After surgery, treatment includes radiation to the brain and spinal cord (in children ages 3 and up at diagnosis) followed by chemotherapy. Radiation therapy is generally delayed in very young children due to the risks to the developing brain. For children diagnosed with PNET as infants or toddlers, chemotherapy is used alone after surgery.

Prognosis

Prognosis means a prediction of outcome. This information is usually based on information gathered from groups of people with the same disease. It is important to remember these statistics are not individualized.

In 2021, the PNET group of tumors began to be classified differently. Due to this change, prognostic data for PNET is limited.

Incidence

PNET are very rare tumors, accounting for about 100 tumors per year.

Age Distribution

PNET can occur in all ages, most commonly in childhood ages 0-14.

Risk Factors

Like many tumor types, the exact cause of PNET is not known. The risk of developing pineoblastoma is increased in patients with germline mutations in the RB1 or DICER1 genes.

Molecular Profile

Molecular profiling is the detection of specific genes, proteins, or other molecules in a tumor. This information helps confirm tumor diagnosis, inform treatment options, and predict prognosis.

Molecular analyses of the PNET group of tumors such as assessment for mutations or methylation analysis should be clinically performed to obtain a specific diagnosis for tumors in the PNET category in order to provide more specific prognostic information to the patient.  Molecular markers commonly found in the PNET group of tumors include FOXR2 activation, BCOR alteration, CIC alteration, and MN1.

Content last reviewed:

April 2022 by Holly B. Lindsay, MD, MS and Donald Williams (Will) Parsons, MD, PhD

Newly diagnosed?
Start here.

This free “Newly Diagnosed Toolkit” has what you need to get started, including diagnosis, treatment,  tumor-specific information for some tumor types, even a custom notebook and pen to keep track of information from your doctor visits.

Subscribe to MindMatters

Sign up for our bi-monthly email to get the latest news on treatments, support, and stories from the brain tumor community.

Our Support Services are 100% free for patients and caregivers

CareLine

800-886-ABTA (2282) 8:30 AM-5:00 PM CST or info@abta.org
- Information on treatment and care
- Finding brain tumor treatment centers
- Financial assistance resources
- Finding clinical trials

Support Groups

From diagnosis, surgery, and treatment side effects, to recovery and for some—recurrence—you may feel anxious and isolated. Support groups can improve your emotional well-being and quality of life. Virtual and in-person options.

Patient & Caregiver Mentor Support

Our Mentor Program offers patients and caregivers the opportunity to connect with someone who has gone through a similar brain tumor diagnosis, treatment, and care.

Financial Support

Being diagnosed with a brain tumor takes a toll physically, emotionally, and financially. Medical bills and related costs can quickly add up. We have a list of resources to help in addition to the ABTA Financial Assistance Program.

Webinars

The free educational webinar series is an excellent resource for brain tumor patients and caregivers to learn more about brain tumor types, treatments, well-being topics, and research updates from nationally recognized experts.

Educational Resources

- About Brain Tumors
- Questions to Ask Your Doctor
- Tumor-specific educational materials
- Caregiver Handbook
- Clinical Trials
and more

Connections Community

ABTA’s online support community, where brain tumor patients, survivors, and caregivers come together. Information about malignant and non-malignant tumors, GBM, immunotherapy and more.

Patient Family Meetings

Each free, half-day program in this series focuses on a specific topic for brain tumor patients and caregivers, led by nationally recognized experts. Watch one or all. Similar to our Webinars but longer and more in-depth.

Brain Tumor Treatment Center

The ABTA Treatment Center Guide provides detailed information about a variety of treatment centers, including the number of patients treated annually, technologies and specialized procedures offered.

Gina & Tim Abbas
Caregiver & Anaplastic Astrocytoma Survivor

Give Now

Accelerate Groundbreaking Research & Expand Patient Services

800+ children & adults are diagnosed with a brain tumor every single day.